The evidence base

A mechanistic mini-review explaining how the vagus nerve — 80% listening (afferent), only 20% commanding (efferent) — physically bridges the gut microbiota and the brain. Vagal nerve endings sit just beneath the gut wall, sensing bacterial metabolites and gut hormones without ever touching the microbiota directly, then relaying that signal into the brain's central autonomic network. The paper's clearest causal evidence comes from Bravo et al. (2011): mice fed a specific probiotic strain showed reduced anxiety and altered brain GABA expression — but only when the vagus nerve was intact, with the effect vanishing after vagotomy. The vagus also runs a cholinergic anti-inflammatory pathway that dampens gut inflammation and reinforces the gut lining, while stress does the opposite — suppressing vagal tone and increasing gut permeability.

Human anatomy dataset. This open, ongoing reconstruction follows the left and right vagus nerve from the brainstem through the neck, chest and abdomen using dissection, ultrasound, microCT and tissue staining. Its cross-registered images map branches, fascicles and individual fibres to help researchers understand the nerve's intricate organisation and design more selective neuromodulation. This release reports one adult female donor, so it is a detailed anatomical resource rather than population-level evidence.

Peer-reviewed essay summarising how vagal sensory neurons distinguish three essential features of an internal signal: which organ it comes from, which tissue layer receives it, and what kind of stimulus it carries. Drawing on mouse work using single-cell sequencing, whole-organ imaging and calcium imaging, it presents the vagus not as one general-purpose cable but as a multidimensional, combinatorial communication system. The translational promise is substantial, but the detailed coding evidence remains preclinical.

Scientific commentary connecting emerging human vagus anatomy with mechanistic mouse studies and human psychophysics. It argues that anatomy alone cannot explain whether a bodily signal becomes organ-specific or general: context, task demands and neural processing also determine what the signal means. The piece is an expert synthesis rather than a peer-reviewed primary study, and it clearly identifies the limits of moving between cadaver anatomy, animal experiments and living human experience.

Mouse preprint; not yet peer reviewed. The researchers created an interoceptive psychophysics task in which mice reported non-invasive activation of gut mechanosensory neurons. Activity in the insular cortex consistently represented the gut stimulus, but encoded the animal's perceptual report only during the more difficult task; altering insular activity changed behaviour in that condition too. The study offers a causal framework for asking when an internal gut signal becomes a reportable perception, while its relevance to human awareness remains to be established.

Peer-reviewed methods paper introducing hierarchical models for cardiac and respiratory interoception tasks. Rather than collapsing performance into one accuracy score, the approach separates perceptual bias, sensitivity, precision and occasional lapses while retaining uncertainty at both individual and group levels. Validation with data from hundreds of participants suggests researchers can draw stronger inferences from fewer trials, an important advance for clinical and paediatric studies, though the gains depend on the task, prior assumptions and study design.

Peer-reviewed human neuroimaging study of 536 healthy participants. It identifies a stable tendency for the resting mind to turn toward visceral and bodily experience. More body-focused thought was associated in the moment with negative affect, greater arousal and stronger connectivity between thalamic, somatomotor and interoceptive-allostatic networks; unexpectedly, people with a greater tendency toward this state reported fewer trait-level symptoms of depression and ADHD. The result is correlational, but it shows that even apparently idle thought remains deeply embodied.

Scientific commentary questioning the common practice of dividing the cardiac cycle into broad systole and diastole windows. Because electrical activation, blood ejection, pressure waves, receptor firing and central processing unfold on different and variable timescales, those bins may blur or mislabel the signal of interest. The author argues for continuous, physiology-led models using beat-to-beat haemodynamics and explicit sensory pathways. It is a methodological argument grounded in prior studies, not a new experiment.

A mechanistic study from the Benakis lab at LMU Klinikum (Institute for Stroke and Dementia Research) tracing a complete gut-to-brain pathway. In a patient cohort with ischemic stroke, higher abundance of tnaA — the gut bacterial gene that converts dietary tryptophan into indole — was associated with poorer functional outcome. Mouse experiments then showed the mechanism: indole-producing bacteria worsened brain injury by activating the aryl hydrocarbon receptor (AHR) in intestinal dendritic cells. Switching AHR off in those cells changed their behaviour completely — they migrated from the gut to the meninges, promoted protective regulatory T cells, and reduced brain damage. Honest structure of the evidence: the mechanism is established in mice, while the human data are correlational, linking a bacterial gene to outcome rather than proving causation. Also notable: the indole produced is shaped by diet, since tryptophan comes from food.

A 17-week randomized controlled trial from Stanford (Sonnenburg and Gardner labs) directly comparing two microbiota-targeted diets in healthy adults: one high in fiber, one high in fermented foods (yogurt, kefir, kimchi, kombucha, fermented vegetables). The result was genuinely surprising to the researchers themselves: the fermented-food diet steadily increased gut microbiota diversity and lowered 19 distinct inflammatory markers in the blood, while the high-fiber diet — despite increasing fiber-digesting microbial enzyme activity — did not meaningfully shift microbiota diversity or reduce inflammation over this timeframe. The likely explanation is that fiber's benefits depend on already having the right microbes present to break it down, while fermented foods directly introduce live, diverse microbial populations.

Published August 2026. Sets out the perpetuating cycle linking HPA axis dysfunction, inflammation, obesity, insulin resistance and major depression. Reports Mendelian randomisation evidence for a bidirectional causal relationship between type 2 diabetes and depression, and a meta-analysis of 70 studies (n=240,704) finding insulin resistance elevated during acute depressive episodes but not in remission — a state rather than trait marker. Also notes insulin receptors in mood-regulating brain regions, and that exercise shows moderate-to-large effects on depressive symptoms, non-inferior to first-line antidepressants. Honest that evidence for insulin-sensitising drugs as antidepressants remains mixed.

The Vagus Nerve as Translator Between your gut and your brain runs a conversation conducted largely without words — chemical signals, microbial metabolites, and a wandering cranial nerve that reaches from your brainstem down through nearly every organ in your torso. A 2023 review in Acta Diabetol traces how this "microbiota-gut-brain axis" works: gut bacteria interact with enteroendocrine cells lining the intestine, which in turn signal the brain via the vagus nerve and hormones like GLP-1 — shaping not just digestion, but appetite, and even how we learn to prefer certain foods over time. The stakes are more than academic. The authors connect this signaling network directly to the twin epidemics of obesity and type 2 diabetes — conditions so metabolically entangled the paper uses the term "diabesity" to describe them. Their argument: the vagus nerve isn't just a passive conduit for satiety signals, it's an active site where gut microorganisms may influence feeding behavior and metabolic health. This is the physiology our table is built to trace — a literal, walkable map of the same nerve.

The mechanism behind slow exhalation and parasympathetic activation.

Oleocanthal — the peppery catch in good olive oil — has documented anti-inflammatory activity comparable in action to ibuprofen.

Cacao flavanols and cerebral blood flow.

Gentle touch activates a specific class of nerve fibre linked to oxytocin release — in both the person touching and the person touched.

Eating with the hands measurably heightens the sensory experience of food.

A landmark review from Europe's leading nutritional psychiatry researchers establishing that diet quality is linked to mood, cognition, and risk of depression, while candidly acknowledging that causal mechanisms are still being mapped. The paper became a founding reference point for treating food-mood science as a legitimate, if young, field.

A policy commentary from the BRAINFOOD cluster (European Brain Research Area), written by many of the same researchers behind the 2019 nutritional psychiatry review, arguing that Europe is failing to act on evidence it already has. Brain health conditions account for 35% of Europe's disease burden and ~€800 billion a year in cost, yet nutrition — one of the few modifiable risk factors — remains underfunded and poorly communicated. The paper's sharpest point: food products can't be patented the way drugs can, so the pharmaceutical funding model doesn't transfer, and building the evidence base for nutrition-as-intervention has to be a public responsibility, not something left to industry. The authors call for three things: more causal (not just observational) research, better public and clinical education, and sustained cross-sector funding.

A substudy of the landmark PREDIMED trial, this is one of the few genuine randomized controlled trials — not just an observational study — testing whether diet can slow cognitive decline in older adults. Over roughly four years, participants following a Mediterranean diet supplemented with either extra-virgin olive oil or mixed nuts maintained or improved their cognitive scores, while a control group (advised only to reduce dietary fat) showed significant decline across memory, attention, and global cognition. The proposed mechanisms — antioxidant and anti-inflammatory polyphenols, vascular protection, and omega-3-linked brain plasticity — line up with the broader gut-brain and inflammation literature. The trial was later reanalyzed after a protocol irregularity was identified across the parent PREDIMED study; the corrected results held up directionally, reinforcing rather than undermining confidence in the finding.

A rigorously graded review of nutrition-stroke evidence by a stroke neurologist, using the GRADE framework to separate reliable findings (from randomized trials) from weaker observational signal. Its most important contribution is a corrective one: high-quality trials show that antioxidant vitamin supplements (A, E, β-carotene) and calcium supplements do not prevent stroke — and in several cases increase mortality or cardiovascular risk. By contrast, whole dietary patterns (Mediterranean, DASH, high in potassium and fruit/vegetables, low in salt) show more consistent, if still largely observational, protective associations. The review closes with a line worth keeping close at hand: "almost every nutritional 'fact' is in reality an opinion, often based on poor quality evidence."

The field's definitive reference work — a 137-page review from the Cork microbiome-brain research group (John Cryan, Timothy Dinan, and 25 co-authors) synthesizing the entire microbiota-gut-brain axis across the lifespan. It maps every major communication route between gut microbes and the brain — the vagus nerve, the immune system, tryptophan metabolism, and microbial metabolites like short-chain fatty acids — and traces how microbiome composition is shaped from birth (delivery mode, early nutrition, antibiotic exposure) through to age-related decline. It's the paper virtually every other gut-brain study cites as its foundational reference, spanning conditions from anxiety and autism to Parkinson's and Alzheimer's disease.

Origin of the cholinergic anti-inflammatory pathway.

Millisecond-scale vagal signalling from gut to brain.